ABOUT THIS EPISODE

Featuring perspectives from Prof John Seymour, including the following topics:

Safety of fixed-duration acalabrutinib/venetoclax for chronic lymphocytic leukemia (CLL) (0:00)
Venetoclax re-treatment and ongoing trials with acalabrutinib/venetoclax for CLL (6:21)
First-line treatment with sonrotoclax and zanubrutinib for CLL (13:10)

CME information and select publications

Science

Medicine

English

United States

Use API to fetch this episode in JSON

IN THIS EPISODE

prof john seymour

Edit these tags

SHOW NOTES 🔗

00:00:00Safety of fixed-duration acalabrutinib/venetoclax for chronic lymphocytic leukemia (CLL)

00:06:21Venetoclax re-treatment and ongoing trials with acalabrutinib/venetoclax for CLL

00:13:10First-line treatment with sonrotoclax and zanubrutinib for CLL

TRANSCRIPT 🔗

Are you the producer of this podcast? Add a podcast transcript

Need Audio-to-Text? Transcribe with Listen411 in Just 60 Seconds

SEARCH PAST EPISODES

Search past episodes of Hematologic Oncology Update.

Embed this search bar to your website

OTHER EPISODES IN THIS PODCAST

Chronic Myeloid Leukemia — An Interview with Prof Andreas Hochhaus

Sept. 12, 2026

Featuring an interview with Prof Andreas Hochhaus, including the following topics: Biology of chronic myeloid leukemia (CML) and rationale for current therapeutic approaches; importance of cytogenetic testing (0:00) Mechanistic differences among first-generation tyrosine kinase inhibitors (TKIs), …

00:59:49

SAVE

CLIP

Chronic Lymphocytic Leukemia — Rapid Case Review: Microlearning Activity 4

Sept. 7, 2026

Featuring perspectives from Prof John Seymour and cases from Dr Daniel Ermann, Dr Shazia Nakhoda and Dr Mahesh Swaminathan, including the following topics: Case: A woman in her mid 50s with multiple sclerosis, hypertension, IGHV-unmutated chronic lymphocytic leukemia (CLL) with an SF3B1 mutation a…

00:30:54

SAVE

CLIP

Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia — Reviewing Recent Datasets from the 2026 ASCO Annual Meeting and EHA2026 Congress

Sept. 25, 2026

Featuring perspectives from Dr Brad S Kahl, Dr Jeff Sharman and Dr Tanya Siddiqi, including the following topics: Introduction (0:00) Trials in Progress (1:12) Chronic Lymphocytic Leukemia (7:09) Diffuse Large B-Cell Lymphoma (32:35) Mantle Cell Lymphoma (58:25) Follicular Lymphoma (1:14:49) CME i…

01:28:21

SAVE

CLIP

Antibody-Drug Conjugates for Multiple Myeloma — An Interview with Dr Douglas W Sborov

Sept. 23, 2026

Featuring an interview with Dr Douglas W Sborov, including the following topics: DREAMM-2 trial outcomes and clinical development of antibody-drug conjugates for multiple myeloma (MM); mechanism of action of belantamab mafodotin (belamaf) and predictors of response to treatment (0:00) Perspectives…

00:49:41

SAVE

CLIP

Disclaimer: The podcast and artwork embedded on this page are from Dr. Neil Love, which is the property of its owner and not affiliated with or endorsed by Listen Notes, Inc.